Atlas Trials

Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Personalized Approach

Clinical trial NCT02553915 · COMPLETED

Trial details

NCT number
NCT02553915
Sponsor
Massachusetts General Hospital
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Major Depressive DisorderOverweightInflammation
Start date
2015-12-01
Primary completion
2018-07-13
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.